We investigated pretreatment fasting glucose as a predictor of patients' important outcomes in breast and colorectal cancers undergoing targeted therapies.
Barba, M., Sperati, F., Stranges, S., Carlomagno, C., Nasti, G., Iaffaioli, V., et al. (2012). Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort. ANNALS OF ONCOLOGY, 23(7), 1838-1845 [10.1093/annonc/mdr540].
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort
GIORDANO, ANTONIO;
2012-01-01
Abstract
We investigated pretreatment fasting glucose as a predictor of patients' important outcomes in breast and colorectal cancers undergoing targeted therapies.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Fasting glucose and treatment outcome in breast and colorectal cancer patients t.pdf
non disponibili
Tipologia:
PDF editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
214.54 kB
Formato
Adobe PDF
|
214.54 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento:
https://hdl.handle.net/11365/976263
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo